Skip to main content

Advertisement

SpringerLink
Log in

ASO Author Reflection: Isolated Limb Infusion for Locally Advanced Melanoma in the Extremely Old Patient is Safe and Effective

  • ASO Author Reflections
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Weide B, Neri D, Elia G. Intralesional treatment of metastatic melanoma: a review of therapeutic options. Cancer Immunol Immunother. 2017;66:647–56.

    Article  Google Scholar 

  2. Kroon HM, Huismans AM, Kam PCA, Thompson JF. Isolated limb infusion with melphalan and actinomycin-D for melanoma: a systematic review. J Surg Oncol. 2014;109:348–51.

    Article  CAS  Google Scholar 

  3. Teras J, Kroon HM, Miura JT, et al. International multi-center experience of isolated limb infusion for in-transit melanoma metastases in octogenarian and nonagenarian patients. Ann Surg Oncol. 2020. https://doi.org/10.1245/s10434-020-08312-0.

    Article  PubMed  Google Scholar 

  4. Weitman ES, Zager JS. Regional therapies for locoregionally advanced and unresectable melanoma. Clin Exp Metastasis. 2018;35:495–502.

    Article  CAS  Google Scholar 

  5. Ariyan CE, Brady MS, Siegelbaum RH, et al. Robust antitumor responses result from local chemotherapy and CTLA-4 blockade. Cancer Immunol Res. 2018;6:189–200.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgery, Royal Adelaide Hospital, University of Adelaide, Adelaide, SA, Australia

    Jüri Teras MD, FACS & Hidde M. Kroon MD, PhD

  2. Department of Surgical Oncology, North Estonian Medical Centre Foundation, Tallinn, Estonia

    Jüri Teras MD, FACS

  3. Tallinn University of Technology, Tallinn, Estonia

    Jüri Teras MD, FACS

  4. Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia

    Hidde M. Kroon MD, PhD

  5. Department of Cutaneous Oncology, Moffitt Cancer Center and Research Institute, Tampa, FL, USA

    Jonathan S. Zager MD, FACS

  6. Department of Oncological Sciences, Morsani College of Medicine, University of South Florida, Tampa, FL, USA

    Jonathan S. Zager MD, FACS

Authors
  1. Jüri Teras MD, FACS
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hidde M. Kroon MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jonathan S. Zager MD, FACS
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Hidde M. Kroon MD, PhD.

Ethics declarations

Disclosure

Jonathan S. Zager has a patent for high-flow isolated limb infusion.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Teras, J., Kroon, H.M. & Zager, J.S. ASO Author Reflection: Isolated Limb Infusion for Locally Advanced Melanoma in the Extremely Old Patient is Safe and Effective. Ann Surg Oncol 27, 1430–1431 (2020). https://doi.org/10.1245/s10434-020-08314-y

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-020-08314-y

Search

Navigation